CHRNG
MOLECULAR TARGETcholinergic receptor nicotinic gamma subunit
CHRNG (cholinergic receptor nicotinic gamma subunit) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CHRNG
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Nicotine Nicotine is highly toxic alkaloid. It is | 1.39 | 3 |
About CHRNG as a Drug Target
CHRNG (cholinergic receptor nicotinic gamma subunit) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented CHRNG interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CHRNG inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.